Form 4 Filing: Butler John P. Buys $87K of $AKBA

INSIDER PURCHASE

⚡ MATERIALITY: 7/10

corporate issuer

Akebia Therapeutics, Inc.

Ticker: $AKBA

Transaction Value

$87K

Price/Share: $1.25

transaction date

2026-03-04

Shares: 69,270

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Butler John P., holds the title of CEO and President at Akebia Therapeutics, Inc..

On 2026-03-04, the insider transacted 69,270 shares.The shares were transacted at a weighted average price of $1.25 per share, resulting in a total market-relevant value of $87K.

Executive Summary Summary

Butler John P. (CEO and President) bought $87K of $AKBA

Post-Transaction Position: 3,367,064 shares

SEC Accession No: 0001591467-26-000003 (CIK: 1591467)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$AKBA Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$AKBA News Coverage